Related references
Note: Only part of the references are listed.Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus
G. Dultz et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study
E. S. Andersen et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Soluble CD163, a Macrophage Activation Marker, Is Independently Associated With Fibrosis in Patients With Chronic Viral Hepatitis B and C
Konstantin Kazankov et al.
HEPATOLOGY (2014)
Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin
Marek Radkowski et al.
JOURNAL OF GENERAL VIROLOGY (2014)
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs
Addle P. McFarland et al.
NATURE IMMUNOLOGY (2014)
Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis
Masaya Sato et al.
PLOS ONE (2014)
Association of IL28B Genotype With Fibrosis Progression and Clinical Outcomes in Patients With Chronic Hepatitis C: A Longitudinal Analysis
Mazen Noureddin et al.
HEPATOLOGY (2013)
Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma
Oliver Waidmann et al.
JOURNAL OF HEPATOLOGY (2013)
Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis
Oliver Waidmann et al.
JOURNAL OF HEPATOLOGY (2013)
Innate immunity and HCV
Markus H. Heim
JOURNAL OF HEPATOLOGY (2013)
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Barbara Rehermann
NATURE MEDICINE (2013)
Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure
Hong Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hepatic Cell-Type Specific Gene Expression Better Predicts HCV Treatment Outcome Than IL28B Genotype
Ian McGilvray et al.
GASTROENTEROLOGY (2012)
Soluble CD163
Holger J. Moller
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2012)
The Course of Posttransplant Hepatitis C Infection: Comparative Impact of Donor and Recipient Source of the Favorable IL28B Genotype and Other Variables
Andres Duarte-Rojo et al.
TRANSPLANTATION (2012)
Increased Risk of Severe Hepatitis C Virus Recurrence After Liver Transplantation in Patients With a T Allele of IL28B rs12979860
Elisa Cisneros et al.
TRANSPLANTATION (2012)
Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24-72 Weeks
Christoph Sarrazin et al.
GASTROENTEROLOGY (2011)
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
Christoph Sarrazin et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles
T. N. Q. Pham et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
Soluble CD163 from activated macrophages predicts mortality in acute liver failure
Holger Jon Moller et al.
JOURNAL OF HEPATOLOGY (2007)
Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection
Angela Dolganiuc et al.
GASTROENTEROLOGY (2007)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Medical progress: Hepatitis C virus infection.
GM Lauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
